Identifying the Diagnostic Challenges and Indicators of Orthostatic Tremor: Patient Perspectives
Movement Disorders Clinical Practice · 2025
DOI: 10.1002/mdc3.70081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Wietske A Babeliowsky und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Clinical Neurophysiology, Amsterdam University Medical Centers, Amsterdam Neuroscience, University of Amsterdam, Amsterda…. Hauptthemen laut MEDLINE: Tremor, Dizziness, Delayed Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The diagnosis of orthostatic tremor (OT) is challenging because of its non‐specific symptoms and a broad range of differential diagnosis, resulting in a complex and lengthy diagnostic journey.
Objective
The aim was to assess the diagnostic delay in OT and to identify key clinical indicators as reported by patients.
Methods
In 2019, the American OT community developed and distributed a web‐based survey titled “Symptoms and Diagnosis of Orthostatic Tremor (OT).” The survey included questions on demographics, the diagnostic process, and symptomatology.
Results
An international cohort of 360 OT patients participated in the study, of which 147 with electromyography (EMG)‐confirmed and 213 symptom‐based OT. In the EMG‐confirmed OT group, respondents reported an average diagnostic delay of 7.4 (±8.5) years on average, attributed to delays at both the patient and physician level. A diagnosis was made by a movement disorders specialist in 75 (51.0%) of 147 cases. Misdiagnosis initially occurred in 57 (38.8%) of 147 patients, whereas 49 (33.3%) of 147 patients suspected OT before receiving a formal diagnosis. OT was commonly reported a progressive condition. The most frequent symptoms on standing that prompted patients to seek medical attention included: “shakiness/tremors in both legs” (92.5%), “feelings of unsteadiness or imbalance” (75.5%), “toe curling” (61.9%), and the “feeling of falling while standing” (45.6%). Notably, 70.0% of respondents reported experiencing anxiety at least occasionally. These findings closely align with the findings of the symptom‐based OT group.
Conclusion
This study underscores a significant diagnostic delay in OT and identifies key clinical indicators, which could facilitate earlier diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Clinical Neurophysiology, Amsterdam University Medical Centers, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.
- Movement Disorders Section, Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
- American OT Community.
- Miami Neuroscience Institute Baptist Health South Florida, Miami, Florida, USA.
ORCID-Profile: Wietske A Babeliowsky, Bart Swinnen, Rob M A de Bie
Zitieren
APA
Babeliowsky, W. A., Woodward, K., Swinnen, B., Doss, S., Muir, M., de Bie, R. M. A., Torres-Russotto, D. R., & van Rootselaar, A. F. (2025). Identifying the Diagnostic Challenges and Indicators of Orthostatic Tremor: Patient Perspectives. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70081
Vancouver
Babeliowsky WA, Woodward K, Swinnen B, Doss S, Muir M, de Bie RMA, et al. Identifying the Diagnostic Challenges and Indicators of Orthostatic Tremor: Patient Perspectives. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70081
BibTeX
@article{Babeliowsky2025,
author = {Babeliowsky, Wietske A and Woodward, Kiel and Swinnen, Bart and Doss, Sarah and Muir, Michael and de Bie, Rob M A and Torres-Russotto, Diego R and van Rootselaar, Anne-Fleur},
title = {Identifying the Diagnostic Challenges and Indicators of Orthostatic Tremor: Patient Perspectives},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.70081}
}
EUVIMED